Wellbutrin Sr(Bupropion Hcl)
GSK
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by GSK plc
$5.2M
Medicare cost, 2024
$5.2M
Medicare cost, 2024
Medicare drug plans spent $5.2 million on Wellbutrin Sr (bupropion hcl) in 2024, for 6,091 prescriptions and refills filled by 1,307 patients. California accounts for the most spending ($848,318, 16% of the total). It is made by GSK plc (GSK).
Medicare cost, 2024
$5.2M
-9.5% from 2023
Prescriptions
6,091
$852.99 per claim
Patients
1,307
1,530 prescribers
Total spending, 2024
$5.2M
$3,975.16 per patient
Questions and answers
How much does Medicare spend on Wellbutrin Sr?
Medicare prescription drug plans paid $5.2M for Wellbutrin Sr in 2024, for 6,091 prescriptions and refills to 1,307 patients (down 9.5% from 2023). The average cost per claim was $852.99.
Which state spends the most on Wellbutrin Sr?
California had the highest Medicare cost for Wellbutrin Sr in 2024: $848K for 830 claims, followed by New York ($484K).
Who prescribes Wellbutrin Sr the most?
Franklin D Russek, psychiatry in New York, NY, had the highest Medicare cost for Wellbutrin Sr in 2024: 13 claims costing $21K.
Who makes Wellbutrin Sr?
Wellbutrin Sr is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Wellbutrin Sr was $5.2M in 2024, after a high of $6.2M in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Wellbutrin Sr, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Franklin D Russek New York, NY | Psychiatry | 13 | Under 11 | $21K |
| John D Fenley Johnson City, TN | Psychiatry & Neurology | 12 | Under 11 | $20K |
| John A Grimaldi Jr. Boston, MA | Psychiatry | 18 | Under 11 | $20K |
| Alexandra Potock Sewickley, PA | Internal Medicine | 11 | Under 11 | $14K |
| Thomas R Lux Houston, TX | Internal Medicine | 11 | Under 11 | $12K |
| Rashelle Tomlinson Stockbridge, GA | Psychiatry | 13 | Under 11 | $12K |
| Robert J Sevenich Saint Paul, MN | Psychiatry | 11 | Under 11 | $12K |
| Ashley McCorkle Buffalo, NY | Internal Medicine | 13 | Under 11 | $11K |
| Pilar Lachhwani Cleveland, OH | Psychiatry | 11 | Under 11 | $11K |
| Thomas D Long Jr. Roxboro, NC | Internal Medicine | 13 | Under 11 | $11K |
| Jeffrey B Warren Loveland, CO | Psychiatry | 13 | Under 11 | $11K |
| Jane Simon New York, NY | Psychiatry & Neurology | 12 | Under 11 | $11K |
| James P Reed Sierra Vista, AZ | Psychiatry | 16 | Under 11 | $11K |
| Stephen D Henry Pasadena, CA | Internal Medicine | 12 | Under 11 | $10K |
| Aloysius L Davis Longmeadow, MA | Psychiatry | 12 | Under 11 | $10K |
| Jessica S Lucero Las Vegas, NV | Nurse Practitioner | 12 | Under 11 | $10K |
| Samuel G Welch Mt Sterling, KY | Psychiatry | 12 | Under 11 | $10K |
| Marjorie A Harelick Arlington, VA | Psychiatry | 12 | Under 11 | $10K |
| Mary E Daly Saginaw, MI | Nurse Practitioner | 12 | Under 11 | $10K |
| Donald D Scalea Marlton, NJ | Psychiatry & Neurology | 12 | Under 11 | $10K |
| Emily E Bucy Boulder, CO | Psychiatry | 12 | Under 11 | $10K |
| Kathy D Mayo Greenville, NC | Psychiatry & Neurology | 12 | Under 11 | $10K |
| Birgit Amann Troy, MI | Psychiatry | 13 | Under 11 | $10K |
| Anne E Marmorale Glen Oaks, NY | Nurse Practitioner | 12 | Under 11 | $10K |
| Suzanne M Kontak Ronkonkoma, NY | Nurse Practitioner | 15 | Under 11 | $9,991 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,711 | 6,938 | 1,466 | $5.7M |
| 2023 | 1,595 | 6,588 | 1,370 | $5.7M |
| 2024 | 1,530 | 6,091 | 1,307 | $5.2M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline | 6,091 | $5.2M |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 3
- RxNorm concept IDs
- 993503, 993511, 993518, 993528, 993536
- Application numbers
- NDA020358
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 154,303 side-effect reports named bupropion hydrochloride, the active ingredient of Wellbutrin Sr (reports from 2000 on). 84,655 of them (54.9%) were serious, 13,596 named a death and 34,665 named a hospital stay. The reactions named most often were drug ineffective, nausea and fatigue. 49,558 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
154,303
11,812 in 2025 (+5.6% from 2024)
Serious
54.9%
84,655 reports
Deaths named
13,596
8.8% of reports
Hospital stays
34,665
22.5% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
Since 2002. 2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Wellbutrin Sr?
154,303 reports from 2000 through September 2026 named bupropion hydrochloride, the active ingredient of Wellbutrin Sr. 84,655 of them (54.9%) were serious, 13,596 named a death and 34,665 named a hospital stay.
What are the most reported side effects of Wellbutrin Sr?
13,384 reports named drug ineffective, the reaction named most often, followed by nausea (12,066) and fatigue (10,214). In the last 5 years the reaction named most often was nausea (4,251 reports). A report can name several reactions.
How many side-effect reports named Wellbutrin Sr in 2025?
11,812 reports were received in 2025 (+5.6% from 2024). 2026 so far: 7,758 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Wellbutrin Sr caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Wellbutrin Sr caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with bupropion hydrochloride: Wellbutrin Xl, Forfivo Xl
- Makers on the stock market:
BHC
GSK·BHC drug pipeline - Drug approvals (3 approvals on file for bupropion hydrochloride) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (bupropion hydrochloride) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.